Nov 2023 $107 M No. 6 $50 to $250 million 43
RefleXion Medical, Inc.: Raise no. 6, Nov 2023 × Investors in this round 43 investors had bought by the notice of Nov 22, 2023: 43 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $107 M of $201 M offered; $95 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David T. Larkin · Executive Officer Diana J. King · Executive Officer Gopinath J. Kuduvalli · Executive Officer Jeffrey T. Holifield · Executive Officer Judy J. Bartlett-Roberto · Executive Officer Kathy J. O'Shaughnessy · Executive Officer Leena J. Kadakia · Executive Officer Leonard J. Lyons · Executive Officer Martyn T. Webster · Executive Officer Philip J. Aulson II · Executive Officer Samuel Mazin · Executive Officer, Director Sean T. Shirvani · Executive Officer Thorsten J. Melcher · Executive Officer Todd Powell · Executive Officer, Director Alice T. Schroeder · Director Art T. Heidrich · Director Cem T. Usakli · Director Fred Moll · Director Greg Garfield · Director Jay Watkins · Director Kevin T. Reilly · Director Matthew T. Hobart · Director Rana T. Al-Hallaq · Director Renee T. Ryan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Jeffrey Holifield, Vice President, Head of Legal. Source: SEC Form D, newest notice filed Nov 22, 2023. Read the notice at the SEC .
equity, options SEC Mar 2022 $81 M No. 5 $50 to $250 million 31
RefleXion Medical, Inc.: Raise no. 5, Mar 2022 × Investors in this round 31 investors had bought by the notice of Mar 16, 2022: 31 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $81 M of $110 M offered; $29 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David J. Leung · Executive Officer David Larkin · Executive Officer Gopinath Kuduvalli · Executive Officer Jeff J. Holifield · Executive Officer Judy J. Bartlett-Roberto · Executive Officer Kathy J. O'Shaughnessy · Executive Officer Leonard J. Lyons · Executive Officer Martyn Webster · Executive Officer Philip J. Aulson II · Executive Officer Samuel Mazin · Executive Officer, Director Sean Shirvani · Executive Officer Thorsten Melcher · Executive Officer Todd Powell · Executive Officer, Director Alice Schroeder · Director Antoine Papiernik · Director Cem Usakli · Director Fred Moll · Director Greg Garfield · Director Jay Watkins · Director Matthew Hobart · Director Rana Al-Hallaq · Director Renee Ryan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Jeff Holifield, Vice President and Head of Legal. Source: SEC Form D, newest notice filed Mar 16, 2022. Read the notice at the SEC .
equity SEC Apr 2020 $100 M No. 4 $50 to $250 million 17
RefleXion Medical, Inc.: Raise no. 4, Apr 2020 × Investors in this round 17 investors had bought by the notice of Apr 17, 2020: 17 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $100 M of $125 M offered; $25 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $2,000,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Martyn Webster · Executive Officer Samuel Mazin · Executive Officer, Director Todd Powell · Executive Officer, Director Antoine Papiernik · Director Bill Burkoth · Director Fred Moll · Director Greg Garfield · Director Jay Watkins · Director Loic Jule · Director Matthew Hobart · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Morgan Stanley & Co. LLC (CRD 8209) · New York, New York Sold in all US states BofA Securities, Inc. (CRD 283942) · New York, New York Sold in all US states Remarks in the notice On fees: “Sales commissions estimates are for the total amount sold as recorded in item 13 and evenly divided between the two recipients recorded in item 12.”Signed by Martyn Webster, Secretary and CFO. Source: SEC Form D, newest notice filed Apr 17, 2020. Read the notice at the SEC .
equity SEC Mar 2018 $97 M No. 3 $50 to $250 million 18
RefleXion Medical, Inc.: Raise no. 3, Mar 2018 × Investors in this round 18 investors had bought by the notice of Apr 2, 2018: 18 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $97 M of $103 M offered; $6 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Samuel Mazin · Executive Officer, Director Todd Powell · Executive Officer, Director Antoine Papiernik · Director Bill Burkoth · Director Fred Moll · Director Greg Garfield · Director Jay Watkins · Director Matthew Hobart · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Todd M. Powell, President and ceo. Source: SEC Form D, newest notice filed Apr 2, 2018. Read the notice at the SEC .
equity SEC Apr 2016 $23 M No. 2 $10 to $50 million 5
RefleXion Medical, Inc.: Raise no. 2, Apr 2016 × Investors in this round 5 investors had bought by the notice of Apr 19, 2016: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $23 M of $52 M offered; $29 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Akshay Nanduri · Executive Officer, Director Samuel Mazin · Executive Officer, Director Antoine Papiernik · Director Colin Cahill · Director Fred Moll · Director Greg Garfield · Director Jay Watkins · Director Nael Kassar · Director William Burkoth · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Samuel Mazin, President. Source: SEC Form D, newest notice filed Apr 19, 2016. Read the notice at the SEC .
equity SEC Mar 2014 $6 M No. 1 $2 to $10 million 19
RefleXion Medical, Inc.: Raise no. 1, Mar 2014 × Investors in this round 19 investors had bought by the notice of Apr 4, 2014: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $12 M offered; $6 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $80,000 (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Akshay Nanduri · Executive Officer, Director Samuel Mazin · Executive Officer, Director Jay Watkins · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Samuel Mazin, President. Source: SEC Form D, newest notice filed Apr 4, 2014. Read the notice at the SEC .
equity SEC